129 related articles for article (PubMed ID: 24344117)
1. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.
Wang Z; Liu Y; Zhang P; Zhang W; Wang W; Curr K; Wei G; Mao JH
Oncotarget; 2013 Dec; 4(12):2476-86. PubMed ID: 24344117
[TBL] [Abstract][Full Text] [Related]
2. The FBXW7-binding sites on FAM83D are potential targets for cancer therapy.
Jiang X; Wang Y; Guo L; Wang Y; Miao T; Ma L; Wei Q; Lin X; Mao JH; Zhang P
Breast Cancer Res; 2024 Mar; 26(1):37. PubMed ID: 38454442
[TBL] [Abstract][Full Text] [Related]
3. MYC is a critical target of FBXW7.
Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
[TBL] [Abstract][Full Text] [Related]
4. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
5. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
[TBL] [Abstract][Full Text] [Related]
6. METTL3 regulates FAM83D m
Yu X; Li Y; Kong F; Xu Q
Toxicol In Vitro; 2024 Mar; 95():105746. PubMed ID: 38043628
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
Baxter JS; Brough R; Krastev DB; Song F; Sridhar S; Gulati A; Alexander J; Roumeliotis TI; Kozik Z; Choudhary JS; Haider S; Pettitt SJ; Tutt ANJ; Lord CJ
Mol Oncol; 2024 Feb; 18(2):369-385. PubMed ID: 37866880
[TBL] [Abstract][Full Text] [Related]
8. FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S; Leng P; Guo J; Zhou H
J Exp Clin Cancer Res; 2023 Sep; 42(1):226. PubMed ID: 37658431
[TBL] [Abstract][Full Text] [Related]
9. FAM83D acts as an oncogene by regulating cell cycle progression via multiple pathways in synovial sarcoma: a potential novel downstream target oncogene of anlotinib.
Liu ZM; Yuan Y; Jin L
Discov Oncol; 2024 Mar; 15(1):82. PubMed ID: 38512482
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Analysis Revealing FBXW9 as a Potential Prognostic and Immunological Biomarker in Breast Cancer.
Yu S; Liang Z; Fan Z; Cao B; Wang N; Wu R; Sun H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982338
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor FOXP4 inversely governs tumor suppressor genes and contributes to thyroid cancer progression.
Zhou T; Ma N; Zhang YL; Chen XH; Luo X; Zhang M; Gao QJ; Zhao DW
Heliyon; 2024 Jan; 10(2):e23875. PubMed ID: 38293397
[TBL] [Abstract][Full Text] [Related]
12. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Mol Cancer Res; 2014 Aug; 12(8):1156-65. PubMed ID: 24736947
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of FAM83D gene expression across human cancer types.
Walian PJ; Hang B; Mao JH
Oncotarget; 2016 Jan; 7(3):3332-40. PubMed ID: 26678035
[TBL] [Abstract][Full Text] [Related]
14. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
15. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
[TBL] [Abstract][Full Text] [Related]
16. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
17.
Huang M; Ma X; Shi H; Hu L; Fan Z; Pang L; Zhu F; Yang X; Xu W; Liu B; Zhu Z; Li C
Oncotarget; 2017 Sep; 8(43):74479-74493. PubMed ID: 29088801
[No Abstract] [Full Text] [Related]
18. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.
Snijders AM; Lee SY; Hang B; Hao W; Bissell MJ; Mao JH
Mol Oncol; 2017 Feb; 11(2):167-179. PubMed ID: 28078827
[TBL] [Abstract][Full Text] [Related]
19. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma.
Wang D; Han S; Peng R; Wang X; Yang XX; Yang RJ; Jiao CY; Ding D; Ji GW; Li XC
Biochem Biophys Res Commun; 2015 Mar; 458(2):313-20. PubMed ID: 25646692
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
